Chinese Journal of Pharmacovigilance ›› 2026, Vol. 23 ›› Issue (8): 898-903.
DOI: 10.19803/j.1672-8629.20250750

Previous Articles     Next Articles

Pharmacovigilance for general anesthetics

Sa Rina1,2,3, Shi Yanlei1,3,Δ, Ma Yuanyuan5, Ma Yanping5, Pan Xinbo6, Liang Xi7, Ge Bin1, Lu Jinjing2, Zhang Bing2,8,*   

  1. 1Department of Pharmacy, Gansu Provincial Hospital, Lanzhou Gansu 730000, China;
    2Zhang Bing's Studio of Qi-Huang Scholars, Gansu Provincial Hospital, Lanzhou Gansu 730000, China;
    3Laboratory of Integrated Traditional Chinese and Western Medicine, Gansu Provincial Hospital, Lanzhou Gansu 730000, China;
    4School of Pharmacy, Gansu University of Chinese Medicine, Lanzhou Gansu 730000, China;
    5Department of Pharmacy, Linxia People’s Hospital, Linxia Gansu 731100 China;
    6Institute of Hepatology, The Second People’s Hospital of Lanzhou, Lanzhou Gansu 730000, China;
    7Department of Anesthesiology, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou Gansu 730000, China;
    8School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China
  • Received:2025-10-27 Online:2026-08-15 Published:2026-08-17

Abstract: Objective To explore ways to use general anesthetics safely and establish a perioperative pharmacovigilance system so as to improve the quality of anesthesia and ensure surgical safety. Methods By reviewing the latest literature, the priorities of pharmacovigilance concerning commonly used general anesthetics were summarized, and a full-cycle strategy for pharmacovigilance was constructed that involved “pre-anesthesia assessment of risks-individualized regimens-perioperative real-time monitoring- management of postoperative recovery”. Measures to strengthen pharmacovigilance for surgical anesthesia were recommended. Results This strategy for full-cycle pharmacovigilance identified the major risks posed by anesthetics. Through institutionalized management, this strategy could do much to reduce the risk of drug-related adverse events and enhance the precision of perioperative management. Conclusion A strategy for full-cycle pharmacovigilance and a localized pathway for implementation have been established, which is expected to provide a valuable reference for optimizing the management of general anesthetics in medical institutions and for boosting the construction of safety systems for anesthesia.

Key words: General Anesthetics, Risk Monitoring, Precision Anesthesia, Proactive Monitoring, Practice, Pharmacovigilance

CLC Number: